Bachelor of Pharmacy (B.Pharm.) 

at Rai University Ahmedabad, Ahmedabad

BPharm comes under Rai University School of Pharmacy. The course covers a duration of 4 years. The admission procedure proceeds with the eligibility criteria i.e. 12 years of schooling with PCB/PCM from recognised Board. Further, filling the application form online or offline and uploading all the required documents. Based on the above criteria merit list will be out and a personal interview will be conducted. Also, based on the state level entrance exam like GUJCET and NEET selection process is done. And finally after completing all the procedure, candidates are required to pay the course specific fee and finalise their seat in the University.

The admission process for the BPharma course at Rai University is quite straightforward. Applicants are required to have a valid score in their Class 12 exam, and no entrance exam is necessary. Candidates simply need to meet the BPharma eligibility criteria and apply through the official website of Rai University. The admission process is simple and can be completed in a few steps. Eligible students can easily apply for the course.

The placement rate for BPharm, UG (3-year) courses has been fluctuating over the past three years. Alongside, an improving trend was recorded in the UG (4-year) placement rate. Refer to the table below to know the Rai University placement percentage trends:

NOTE: The above percentage is calculated from the details given in the NIRF report 2024.

The seat intake for BPharm at Rai University is around 100. The seat are only offered to candidates who completes the enire admission procedure. BPharma course is a four-year course offered in the field of pharmacy, covering various aspects from manufacturing to dispensing of drugs. The UG-level course is spread across eight semesters covering major topics in drug development, discovery, and regulation. Pharmaceutics, medicinal chemistry, pharmacognosy, pharmaceutical analysis and pharmacology. 

Yes, ther are scholarships for BPharm course students at Rai University. The scholarships are offered in the form of fee waiver. Candidates must qualify the elgibility criteria for the scholarshisp. The Rai University scholarships are listed below:

To get admission at Rai University for the BPharma programme, candidates must complete a step-wise admission procedure. This procedure includes an online application process, selection process, fee payment, and final admission. Before applying, candidates must ensure they meet the BPharma eligibility criteria, which require a Bachelor's degree in any discipline with a minimum 50% aggregate from a recognised board. Eligible candidates can access the Rai University BPharma application form by registering on the official website of Rai University. 

The University has a decent placement record. The table below depicts the course-wise total strength and the number of students placed over the past three years of Rai University placements:

NOTE: The above details are gathered from the NIRF report 2024.

Yes, Rai University's student can avail Government Scholarship. MukhymantriYuvaSwavalambanYojana (MYSY Scholarship) is one of the scholarship scheme is offered to the students of economically weaker section of Gujarat from the Government. The eligibility criteria for this scheme is as follows:

•  Candidate should be a domicile of Gujarat State
•  The candidate should be enrolled in the first year of the diploma/ degree program.
• The annual family income of the applicant should be less than INR 6,00,000 including all sources of income.
• The applicants who are pursuing a DiplomaLevel/Graduation levelprogram should have obtained a minimum 80% marks at Class 10, Class 12 level. Students pursuing Diploma to Degree (D2D) programs should have obtained at least 65% marks at Diploma level.

The official placement report is yet to be released. Meanwhile, the important data related to Rai University placements 2023 fetched from the NIRF report are mentioned below:

 NOTE: The aforementioned placement data is fetched from the NIRF Report 2024.